Adderall [Bioanalytics]

posted by jag009  – NJ, 2012-05-22 23:31 (5148 d 20:10 ago) – Posting: # 8607
Views: 3,784

Hi Everyone,

As per FDA, BE studies for Mixed Amphetamine (Adderall, Adderall XR) requires measurement of both D- and L-amphetamine in the plasma. What about the requirement of 5% difference in relative potency (total Assay) between test and reference product? Does one have to demonstrate that on both D and L forms of amphetamine?

Thanks

John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
366 visitors (0 registered, 366 guests [including 19 identified bots]).
Forum time: 19:42 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5